NICOLE DELLAIRO: Open Payments
NPI 1013229806 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 12 payments from 7 companies in 2025. Trend: 2023 $946 · 2024 $719 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 5 | $221 |
| Novo Nordisk Inc | 2 | $60 |
| HEARTFLOW, INC. | 1 | $53 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| PFIZER INC. | 1 | $17 |
| Amgen Inc. | 1 | $17 |
Products named: AVEIR, Wegovy, FFRct, LEQVIO, VYNDAQEL, REPATHA.
Industry payments across AZ — which companies pay providers there.
